Medical technology firm Olympus has introduced new EZDilate multi-stage endoscopic balloon dilator, which received 510(k) approval from the US Food and Drug Administration (FDA).
The company has developed the new dilator to provide improved precision and control in endoscopic balloon dilation procedures.
EZDilate offers gastroenterologists with effective navigation through difficult anatomy, easier placement and positioning within the stricture and accurate achievement of target diameters, according to Olympus.
Olympus Corporation of the Americas Medical Systems Group sales and marketing executive vice-president Richard Reynolds said: "This new device is exciting for its advancements in balloon dilation precision and also because of the opportunities it presents our customers for accessing a more complete and cost-effective line-up of EndoTherapy devices from Olympus.
"The announcement builds upon our continuing commitment to the triple aim of healthcare reform – increased quality of care, reduced costs and improved patient satisfaction."
The company will showcase the ZDilate balloon dilator at the New York Society of Gastrointestinal Endoscopy (NYSGE) in Manhattan, which will take place between 17 and 18 December.
According to Truven Health Analytics, around 492,000 balloon dilations are conducted each year in the US.
In September this year, Olympus introduced a new CleverCut3V Distal Wireguided sphincterotome (CleverCut3V DW), which enhances safety and efficiency through advanced technology such CleverCut coating.
Image: Olympus’ new EZDilate multi-stage endoscopic balloon dilator. Photo: courtesy of PRNewsFoto / Olympus.